![CD30](https://www.adcreviews.com/wp-content/uploads/2022/11/CD30-231x160.jpg)
Update on clinical trials of AFM13 therapy
On November 3, Affimed announced that it will present an update on the ongoing Phase I/II clinical trial at the ASH Congress. The study was
On November 3, Affimed announced that it will present an update on the ongoing Phase I/II clinical trial at the ASH Congress. The study was